Frontlight ResearchEarly access
WithdrawnPhase 2
Reusable Face Masks to Reduce Risk of Viral Respiratory Infections and Asthma Exacerbations
Key facts
- Who runs it
- Queen Mary University of London
- Where
- United Kingdom1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Withdrawn
- Phase
- Phase 2
- Started
- 27 Mar 2025
- Ended
- 1 Apr 2025
- Type of study
- Interventional, 2 groupsOne group gets no study treatment, for comparison.
- Treatments tested
- FloMask - reuseable face mask
- Record updated
- 20 May 2025
- Why it stopped
- Diminished minimum sample size needed to detect any effect of the intervention due to TwiCs study design, control arm participants were already recruited to the parent study (COVIDENCE UK).
Who can take part
- Age
- 16 years and older
- Sex
- Women and men
- Healthy volunteers
- Can take part
The registry criteria, word for word
Show all 12 criteriaShow less
Who can take part
- Aged 16 or more years
- Doctor diagnosis of asthma
- Current prescription for treatment of asthma
- Participant in COVIDENCE UK nasal swab study
- Age 16 or more
- Living in same household as index participant who has consented to take part in trial
Who cannot take part
- Regularly using any FFP-rated face mask when in an indoor public place
- Currently sharing household with one or more children
- Currently sharing household with one or more other COVIDENCE UK participants who have asthma
- Unable to tolerate wearing face mask; Eligibility criteria, household members of index participants:
- Unable to tolerate wearing face mask
Other criteria
- Eligibility criteria, participants with asthma ('index participants'):
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
REMASK trial is a Trial within Cohort study (TwiCs), nested within the COVIDENCE UK longitudinal study. It has been designed to determine whether the offer of a free reusable, elastomeric face mask to adults with asthma and other members of their household reduces risk of RT-PCR confirmed viral respiratory infections and asthma exacerbations.
The 2 groups in the trial
- InterventionTreatment being tested
Offer of free reusable elastometic face mask and 12-month supply of replaceable filters to index participants with asthma and their adult household members
Treatment: FloMask - reuseable face mask
- ControlNo study treatment, for comparison
Usual asthma care without offer of intervention above
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Reuseable Face Masks to Reduce Risk of Viral Respiratory Infections and Exacerbations in Adults With Asthma: a Randomised Controlled Trial
- Record updated
- 20 May 2025